Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.730
-0.070 (-3.89%)
Feb 21, 2025, 4:00 PM EST - Market closed
BCLI's stock price has decreased by -67.96% in the past year and price targets may not have had time to catch up.
BCLI Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$30.00
Upside
+1,634.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +1,634.10% | Jul 11, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 28, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $75 → $150 | Strong Buy | Maintains | $75 → $150 | +8,570.52% | Mar 31, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 5, 2021 |
| Maxim Group | Maxim Group | Strong Buy Maintains $120 → $135 | Strong Buy | Maintains | $120 → $135 | +7,703.47% | Aug 17, 2017 |